Advertisement
Screener

ZYNERBA PHARMACEUTICALS, INC. Stock-Based Compensation

ZYNERBA PHARMACEUTICALS, INC. Stock-Based Compensation

ZYNERBA PHARMACEUTICALS, INC. reported Stock-Based Compensation of $1.59 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2023-08-14

  • ZYNERBA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $768.58K, a 30.67% decline year-over-year.
  • ZYNERBA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2023-03-31 was $821.99K, a 29.17% decline year-over-year.
  • ZYNERBA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2022-12-31 was $1.02M, a 1.90% decline year-over-year.
  • ZYNERBA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2022-09-30 was $1.04M, a 33.69% decline year-over-year.
  • ZYNERBA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $4.33M, a 25.45% decline from fiscal 2021.
  • ZYNERBA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $5.81M, a 12.23% increase from fiscal 2020.
  • ZYNERBA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2020 was $5.18M, a 6.91% decline from fiscal 2019.
  • ZYNERBA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $5.56M, a 16.06% decline from fiscal 2018.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2023-06-30$768.58K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$1.59M
10-Q · filed 2023-08-14
$2.61M
derived: sum of 3 quarters · filed 2023-08-14
$3.65M
derived: sum of 4 quarters · filed 2023-08-14
2023-03-31$821.99K
10-Q · filed 2023-05-15
$1.84M
derived: sum of 2 quarters · filed 2023-05-15
$2.88M
derived: sum of 3 quarters · filed 2023-05-15
$3.99M
derived: sum of 4 quarters · filed 2023-08-14
2022-12-31$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
$2.06M
derived: sum of 2 quarters · filed 2023-03-28
$3.17M
derived: sum of 3 quarters · filed 2023-08-14
$4.33M
10-K · filed 2023-03-28
2022-09-30$1.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$2.15M
derived: sum of 2 quarters · filed 2023-08-14
$3.31M
10-Q · filed 2022-11-14
$4.35M
derived: sum of 4 quarters · filed 2023-08-14
2022-06-30$1.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$2.27M
10-Q · filed 2023-08-14
$3.31M
derived: sum of 3 quarters · filed 2023-08-14
$4.88M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$1.16M
10-Q · filed 2023-05-15
$2.20M
derived: sum of 2 quarters · filed 2023-05-15
$3.77M
derived: sum of 3 quarters · filed 2023-05-15
$5.71M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
$2.61M
derived: sum of 2 quarters · filed 2023-03-28
$4.55M
derived: sum of 3 quarters · filed 2023-03-28
$5.81M
10-K · filed 2023-03-28
2021-09-30$1.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$3.50M
derived: sum of 2 quarters · filed 2022-11-14
$4.77M
10-Q · filed 2022-11-14
$6.01M
derived: sum of 4 quarters · filed 2023-03-28
2021-06-30$1.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$3.20M
10-Q · filed 2022-08-10
$4.44M
derived: sum of 3 quarters · filed 2023-03-28
$5.71M
derived: sum of 4 quarters · filed 2023-03-28
2021-03-31$1.26M
10-Q · filed 2022-05-16
$2.51M
derived: sum of 2 quarters · filed 2023-03-28
$3.77M
derived: sum of 3 quarters · filed 2023-03-28
$5.12M
derived: sum of 4 quarters · filed 2023-03-28
2020-12-31$1.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
$2.51M
derived: sum of 2 quarters · filed 2023-03-28
$3.85M
derived: sum of 3 quarters · filed 2023-03-28
$5.18M
10-K · filed 2023-03-28
2020-09-30$1.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$2.61M
derived: sum of 2 quarters · filed 2021-11-15
$3.93M
10-Q · filed 2021-11-15
$5.14M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$1.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$2.67M
10-Q · filed 2021-08-09
$3.88M
derived: sum of 3 quarters · filed 2022-03-01
$5.25M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$1.32M
10-Q · filed 2021-05-12
$2.53M
derived: sum of 2 quarters · filed 2022-03-01
$3.91M
derived: sum of 3 quarters · filed 2022-03-01
$5.39M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$1.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$2.58M
derived: sum of 2 quarters · filed 2022-03-01
$4.07M
derived: sum of 3 quarters · filed 2022-03-01
$5.56M
10-K · filed 2022-03-01
2019-09-30$1.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$2.86M
derived: sum of 2 quarters · filed 2020-11-09
$4.35M
10-Q · filed 2020-11-09
$5.95M
derived: sum of 4 quarters · filed 2021-03-10
2019-06-30$1.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$2.98M
10-Q · filed 2020-08-10
$4.58M
derived: sum of 3 quarters · filed 2021-03-10
$6.16M
derived: sum of 4 quarters · filed 2021-03-10
2019-03-31$1.50M
10-Q · filed 2020-05-11
$3.09M
derived: sum of 2 quarters · filed 2021-03-10
$4.68M
derived: sum of 3 quarters · filed 2021-03-10
$6.44M
derived: sum of 4 quarters · filed 2021-03-10
2018-12-31$1.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10
$3.18M
derived: sum of 2 quarters · filed 2021-03-10
$4.94M
derived: sum of 3 quarters · filed 2021-03-10
$6.63M
10-K · filed 2021-03-10
2018-09-30$1.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$3.34M
derived: sum of 2 quarters · filed 2019-11-06
$5.03M
10-Q · filed 2019-11-06
$6.41M
derived: sum of 4 quarters · filed 2020-03-10
2018-06-30$1.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
$3.44M
10-Q · filed 2019-08-06
$4.82M
derived: sum of 3 quarters · filed 2020-03-10
$6.55M
derived: sum of 4 quarters · filed 2020-03-10
2018-03-31$1.69M
10-Q · filed 2019-05-08
$3.07M
derived: sum of 2 quarters · filed 2020-03-10
$4.79M
derived: sum of 3 quarters · filed 2020-03-10
$6.15M
derived: sum of 4 quarters · filed 2020-03-10
2017-12-31$1.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$3.10M
derived: sum of 2 quarters · filed 2020-03-10
$4.46M
derived: sum of 3 quarters · filed 2020-03-10
$5.65M
10-K · filed 2020-03-10
2017-09-30$1.72M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$3.08M
derived: sum of 2 quarters · filed 2018-11-08
$4.27M
10-Q · filed 2018-11-08
$5.15M
derived: sum of 4 quarters · filed 2019-03-11
2017-06-30$1.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$2.54M
10-Q · filed 2018-08-02
$3.43M
derived: sum of 3 quarters · filed 2019-03-11
$4.24M
derived: sum of 4 quarters · filed 2019-03-11
2017-03-31$1.19M
10-Q · filed 2018-05-08
$2.08M
derived: sum of 2 quarters · filed 2019-03-11
$2.88M
derived: sum of 3 quarters · filed 2019-03-11
$3.69M
derived: sum of 4 quarters · filed 2019-03-11
2016-12-31$887.42K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11
$1.69M
derived: sum of 2 quarters · filed 2019-03-11
$2.51M
derived: sum of 3 quarters · filed 2019-03-11
$3.27M
10-K · filed 2019-03-11
2016-09-30$805.40K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$1.62M
derived: sum of 2 quarters · filed 2017-11-14
$2.38M
10-Q · filed 2017-11-14
$3.15M
derived: sum of 4 quarters · filed 2018-03-12
2016-06-30$812.74K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
$1.58M
10-Q · filed 2017-08-01
$2.34M
derived: sum of 3 quarters · filed 2018-03-12
2016-03-31$763.80K
10-Q · filed 2017-05-09
$1.53M
derived: sum of 2 quarters · filed 2018-03-12
2015-12-31$763.80K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
$1.60M
10-K · filed 2018-03-12
2015-09-30$836.82K
10-Q · filed 2016-11-14